US Stock MarketDetailed Quotes

Galectin Therapeutics (GALT)

Watchlist
  • 2.260
  • -0.300-11.72%
Close Apr 16 15:59 ET
  • 2.335
  • +0.075+3.32%
Post 20:01 ET
148.77MMarket Cap-4.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Galectin Therapeutics (GALT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-52.67%20.09M
-72.92%3.37M
-53.70%4.2M
-59.04%4.63M
-18.15%7.9M
11.45%42.43M
29.99%12.43M
-1.09%9.07M
25.41%11.29M
-6.71%9.65M
Selling and administrative expenses
-1.14%5.8M
8.57%1.43M
7.89%1.59M
-7.71%1.36M
-11.42%1.41M
-1.35%5.86M
-1.05%1.32M
2.58%1.47M
-9.44%1.48M
3.31%1.59M
-General and administrative expense
-1.14%5.8M
8.57%1.43M
7.89%1.59M
-7.71%1.36M
-11.42%1.41M
-1.35%5.86M
-1.05%1.32M
2.58%1.47M
-9.44%1.48M
3.31%1.59M
Research and development costs
-60.93%14.29M
-82.60%1.93M
-65.62%2.61M
-66.77%3.26M
-19.48%6.49M
13.82%36.57M
35.01%11.11M
-1.77%7.6M
33.13%9.81M
-8.47%8.05M
Operating profit
52.67%-20.09M
72.92%-3.37M
53.70%-4.2M
59.04%-4.63M
18.15%-7.9M
-11.45%-42.43M
-29.99%-12.43M
1.09%-9.07M
-25.41%-11.29M
6.71%-9.65M
Net non-operating interest income expense
-38.47%-7.2M
-16.64%-1.91M
-27.12%-1.78M
-51.39%-1.8M
-75.82%-1.71M
-103.04%-5.2M
-112.29%-1.64M
-81.24%-1.4M
-98.17%-1.19M
-133.65%-972K
Non-operating interest income
-62.72%126K
-70.24%25K
-58.06%39K
-67.50%26K
-56.25%35K
46.96%338K
13.51%84K
50.00%93K
60.00%80K
81.82%80K
Non-operating interest expense
32.29%7.33M
12.41%1.94M
21.82%1.82M
43.89%1.83M
65.78%1.74M
98.42%5.54M
103.66%1.73M
78.92%1.49M
95.23%1.27M
128.70%1.05M
Other net income (expense)
-703.40%-3.55M
-110.51%-221K
-192.83%-2.21M
-1,105.50%-1.1M
97.12%-25K
236.11%588K
523.74%2.1M
-53.99%-753K
-77.71%109K
-13.00%-869K
Gain on sale of security
-703.40%-3.55M
-110.51%-221K
-192.83%-2.21M
-1,105.50%-1.1M
97.12%-25K
236.11%588K
523.74%2.1M
-53.99%-753K
-77.71%109K
-13.00%-869K
Income before tax
34.46%-30.84M
54.04%-5.5M
27.06%-8.18M
39.20%-7.52M
16.17%-9.63M
-14.56%-47.05M
-19.71%-11.97M
-7.59%-11.22M
-35.74%-12.37M
0.33%-11.49M
Income tax
Net income
34.46%-30.84M
54.04%-5.5M
27.06%-8.18M
39.20%-7.52M
16.17%-9.63M
-14.56%-47.05M
-19.71%-11.97M
-7.59%-11.22M
-35.74%-12.37M
0.33%-11.49M
Net income continuous Operations
34.46%-30.84M
54.04%-5.5M
27.06%-8.18M
39.20%-7.52M
16.17%-9.63M
-14.56%-47.05M
-19.71%-11.97M
-7.59%-11.22M
-35.74%-12.37M
0.33%-11.49M
Minority interest income
Net income attributable to the parent company
34.46%-30.84M
54.04%-5.5M
27.06%-8.18M
39.20%-7.52M
16.17%-9.63M
-14.56%-47.05M
-19.71%-11.97M
-7.59%-11.22M
-35.74%-12.37M
0.33%-11.49M
Preferred stock dividends
-9.80%138K
-1.59%62K
116.67%39K
-1.56%63K
-425.00%-26K
27.50%153K
0.00%63K
400.00%18K
1.59%64K
8K
Other preferred stock dividends
0
Net income attributable to common stockholders
34.38%-30.97M
53.77%-5.56M
26.83%-8.22M
39.01%-7.58M
16.46%-9.61M
-5.35%-47.2M
-19.58%-12.03M
19.96%-11.24M
-35.50%-12.44M
0.26%-11.5M
Basic earnings per share
36.84%-0.48
57.89%-0.08
27.78%-0.13
40.00%-0.12
21.05%-0.15
-2.70%-0.76
-18.75%-0.19
25.00%-0.18
-33.33%-0.2
0.00%-0.19
Diluted earnings per share
36.84%-0.48
57.89%-0.08
27.78%-0.13
40.00%-0.12
21.05%-0.15
-2.70%-0.76
-18.75%-0.19
25.00%-0.18
-33.33%-0.2
0.00%-0.19
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -52.67%20.09M-72.92%3.37M-53.70%4.2M-59.04%4.63M-18.15%7.9M11.45%42.43M29.99%12.43M-1.09%9.07M25.41%11.29M-6.71%9.65M
Selling and administrative expenses -1.14%5.8M8.57%1.43M7.89%1.59M-7.71%1.36M-11.42%1.41M-1.35%5.86M-1.05%1.32M2.58%1.47M-9.44%1.48M3.31%1.59M
-General and administrative expense -1.14%5.8M8.57%1.43M7.89%1.59M-7.71%1.36M-11.42%1.41M-1.35%5.86M-1.05%1.32M2.58%1.47M-9.44%1.48M3.31%1.59M
Research and development costs -60.93%14.29M-82.60%1.93M-65.62%2.61M-66.77%3.26M-19.48%6.49M13.82%36.57M35.01%11.11M-1.77%7.6M33.13%9.81M-8.47%8.05M
Operating profit 52.67%-20.09M72.92%-3.37M53.70%-4.2M59.04%-4.63M18.15%-7.9M-11.45%-42.43M-29.99%-12.43M1.09%-9.07M-25.41%-11.29M6.71%-9.65M
Net non-operating interest income expense -38.47%-7.2M-16.64%-1.91M-27.12%-1.78M-51.39%-1.8M-75.82%-1.71M-103.04%-5.2M-112.29%-1.64M-81.24%-1.4M-98.17%-1.19M-133.65%-972K
Non-operating interest income -62.72%126K-70.24%25K-58.06%39K-67.50%26K-56.25%35K46.96%338K13.51%84K50.00%93K60.00%80K81.82%80K
Non-operating interest expense 32.29%7.33M12.41%1.94M21.82%1.82M43.89%1.83M65.78%1.74M98.42%5.54M103.66%1.73M78.92%1.49M95.23%1.27M128.70%1.05M
Other net income (expense) -703.40%-3.55M-110.51%-221K-192.83%-2.21M-1,105.50%-1.1M97.12%-25K236.11%588K523.74%2.1M-53.99%-753K-77.71%109K-13.00%-869K
Gain on sale of security -703.40%-3.55M-110.51%-221K-192.83%-2.21M-1,105.50%-1.1M97.12%-25K236.11%588K523.74%2.1M-53.99%-753K-77.71%109K-13.00%-869K
Income before tax 34.46%-30.84M54.04%-5.5M27.06%-8.18M39.20%-7.52M16.17%-9.63M-14.56%-47.05M-19.71%-11.97M-7.59%-11.22M-35.74%-12.37M0.33%-11.49M
Income tax
Net income 34.46%-30.84M54.04%-5.5M27.06%-8.18M39.20%-7.52M16.17%-9.63M-14.56%-47.05M-19.71%-11.97M-7.59%-11.22M-35.74%-12.37M0.33%-11.49M
Net income continuous Operations 34.46%-30.84M54.04%-5.5M27.06%-8.18M39.20%-7.52M16.17%-9.63M-14.56%-47.05M-19.71%-11.97M-7.59%-11.22M-35.74%-12.37M0.33%-11.49M
Minority interest income
Net income attributable to the parent company 34.46%-30.84M54.04%-5.5M27.06%-8.18M39.20%-7.52M16.17%-9.63M-14.56%-47.05M-19.71%-11.97M-7.59%-11.22M-35.74%-12.37M0.33%-11.49M
Preferred stock dividends -9.80%138K-1.59%62K116.67%39K-1.56%63K-425.00%-26K27.50%153K0.00%63K400.00%18K1.59%64K8K
Other preferred stock dividends 0
Net income attributable to common stockholders 34.38%-30.97M53.77%-5.56M26.83%-8.22M39.01%-7.58M16.46%-9.61M-5.35%-47.2M-19.58%-12.03M19.96%-11.24M-35.50%-12.44M0.26%-11.5M
Basic earnings per share 36.84%-0.4857.89%-0.0827.78%-0.1340.00%-0.1221.05%-0.15-2.70%-0.76-18.75%-0.1925.00%-0.18-33.33%-0.20.00%-0.19
Diluted earnings per share 36.84%-0.4857.89%-0.0827.78%-0.1340.00%-0.1221.05%-0.15-2.70%-0.76-18.75%-0.1925.00%-0.18-33.33%-0.20.00%-0.19
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -